DNA repair following exposure of human lymphocytes to 4-nitroquinoline-1-oxide.
D001973:Bromodeoxyuridine / Q000494:pharmacology; D002273:Carcinogens / Q000494:pharmacology*; D002499:Centrifugation, Density Gradient; D003470:Culture Media; D004247:DNA / Q000096:biosynthesis* / Q000528:radiation effects; D004260:DNA Repair / Q000187:drug effects; D004261:DNA Replication / Q000187:drug effects; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation; D008214:Lymphocytes / Q000187:drug effects* / Q000528:radiation effects; D008722:Methods; D011804:Quinolines / Q000494:pharmacology*; D011830:Radiation Effects; D011863:Radioimmunoassay; D013268:Stimulation, Chemical; D013936:Thymidine; D013997:Time Factors; D014316:Tritium; D014466:Ultraviolet Rays
D002273:Carcinogens; D003470:Culture Media; D037102:Lectins; D011804:Quinolines; D014316:Tritium; D004247:DNA; D001973:Bromodeoxyuridine; D013936:Thymidine; D006918:Hydroxyurea